PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2016 | 10 | 2 |

Tytuł artykułu

Infections caused by Borrelia burgdorferi sensu lato

Treść / Zawartość

Warianty tytułu

PL
Zakażenia wywołane przez Borrelia burgdorferi sensu lato

Języki publikacji

EN

Abstrakty

EN
It is justified to systematically monitor the number of those infected with Lyme disease in European countries and conduct the research on spreading of genospecies B. burgdorferi s.l. in animal reservoirs and vectors. Moreover, it is essential to take action for increasing the society’s awareness of tick-borne diseases prophylaxis. It is very important due to the observed increase in the number and activeness of ticks which leads to the increased risk of infection with spirochetes Borrelia burgdorferi sensu lato and other pathogens transmitted by these vectors.

Wydawca

-

Rocznik

Tom

10

Numer

2

Opis fizyczny

p.5-9,ref.

Twórcy

  • Pope John Paul II State School of Higher Education in Biała Podlaska, Sidorska 95/97, 21-500 Biala Podlaska, Poland

Bibliografia

  • 1. Pritt BS, Mead PS, Johnson DK, Neitzel DF, Respicio-Kingry LB, Davis JP et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016 Feb 5; doi: 10.1016/S1473-3099(15)00464-8.
  • 2. Pancewicz SA, Garlicki AM, Moniuszko-Malinowska A, Zajkowska J, Kondrusik M, Grygorczuk S et al. Diagnosis and treatment of tick-borne diseases recommendations of the polish society of epidemiology and infectious diseases. Przegl Epidemiol. 2015; 69(2): 309-316.
  • 3. Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europe. J Public Health. 2016 Mar 9; doi: 10.1093/pubmed/fdw017.
  • 4. Czarkowski MP, Cieleba E, Kondej B, Staszewska E. Infectious diseases and poisonings in Poland in 2013. National Institute of Public Health – National Institute of Hygiene – Department of Epidemiology, Chief Sanitary Inspectorate – Department for Communicable Disease and Infection Prevention and Control. [cited 2 Feb 2016]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2013/Ch_2013.pdf
  • 5. Czarkowski MP, Cieleba E, Kondej B, Staszewska E. Infectious diseases and poisonings in Poland in 2013. National Institute of Public Health – National Institute of Hygiene – Department of Epidemiology, Chief Sanitary Inspectorate – Department for Communicable Disease and Infection Prevention and Control. [cited 2 Feb 2016]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2014/Ch_2014.pdf
  • 6. National Institute of Public Heath, Zachorowania na wybrane choroby zakaźne w Polsce od 1 stycznia do 31 grudnia 2015 r. oraz w porównywalnym okresie 2014 r. [cited 2 Feb 2016]. Available from: http://wwwold. pzh.gov.pl/oldpage/epimeld/2015/INF_15_12B.pdf (in Polish).
  • 7. Wodecka B. Borrelia burgdorferi - charakterystyka ewolucyjna i molekularna. In: Stokarczyk B. editors. Biologia molekularna patogenów przenoszonych przez kleszcze. Warszawa: Wydawnictwo Lekarskie PZWL; 2006. p. 97-104 (in Polish).
  • 8. Maraspin V, Rudzic-Sabljic E, Strle F. Lyme borreliosis and Borrelia spielmani. Emerg Infect Dis. 2006 Jul; 12(7):1177. doi: 10.3201/eid1207.060077
  • 9. Derdakowa M, Lencakowa D. Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology, epidemiology of Lyme borreliosis in Europe. Ann Agric Environ Med. 2005; 12(2): 165-172.
  • 10. Center for Disease Control and Prevention [cited 10 Feb 2016]. Available from: http://www.cdc.gov/ticks/mayonii.html
  • 11. Margos G, Vollmer SA, Ogden N, Durland Fish. Population genetics, taxonomy, phylogeny and evolution of Borrelia burgdorferi sensu lato. Infect Genet Evol. 2011 Oct; 11(7): 1545–1563. doi: 10.1016/j.meegid.2011.07.022.
  • 12. Wodecka B. Krążenie Borrelia burgdorferi s.l. w przyrodzie i lokalizacja w kleszczu. In: Stokarczyk B. editors. Biologia molekularna patogenów przenoszonych przez kleszcze. Warszawa: Wydawnictwo Lekarskie PZWL; 2006. p. 97-104.
  • 13. Zientara M, Martirosian G. Borelioza z Lyme - choroba dzieci i ludzi dorosłych. Nowa Klin. 2010; 17(3): 347-350.
  • 14. Lindgren E, Jeanson TGT. Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. World Health Organization. [cited 2 Feb 2016] Available from: http://www.euro.who.int/__data/assets/pdf_file/0006/96819/E89522.pdf
  • 15. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011 Jan; 17(1):69-79. doi: 10.1111/j.1469-0691.2010.03175.x.
  • 16. European Union Concerted Action on Lyme Borreliosis (EUCALB) [cited 2 Feb 2016] Available from: http://www.eucalb.com/
  • 17. Chmielewski T, Dunaj J, Gołąb E, Gut W, Horban A, Pancewicz S. et al. Diagnostyka laboratoryjna chorób odkleszczowych. Rekomendacje Grupy Roboczej, 2014. [cited 2 Feb 2016] Available from: http://kidl.org.pl/uploads/rekomendacje/05_kleszcze%20z%20okladka.pdf (in Polish).
  • 18. Zaborowski P. Borelioza - trudności diagnostyczne. Terapia. 2012; 20(2): 12-16 (in Polish).
  • 19. Hubálek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genome groups in Europe, a review. Eur J Epidemiol. 1997; 13(8): 951-957.
  • 20. Tijsse-Klasen E, Pandak N, Hengeveld P, Takumi K, Marion PG Koopmans, Hein Sprong. Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates. Parasit. Vectors. 2013 Jan 22. 6:23.doi: 10.1186/1756-3305-6-23
  • 21. Wilske B, Fingerle V, Schulze-Spechtel U. Microbiological and serological diagnosis of Lyme boreliosis. FEMS Immunol Med Microbiol. 2007; 49(1):13-21.
  • 22. Wilske B. Diagnosis of Lyme borreliosis in Europe. Vector-Borne Zoonotic Dis. 2003; 3(4): 215-227.
  • 23. Marangoni A, Sambri V, Accardo S, Cavrini F, Mondardini V, Moroni A, et al. A Decrease in the Immunoglobulin G Antibody Response against the VlsE Protein of Borrelia burgdorferi Sensu Lato Correlates with the Resolution of Clinical Signs in Antibiotic-Treated Patients with Early Lyme Disease. CVI Apr. 2006; 13(4): 525-529. doi:10.1128/CVI.13.4.525–529.2006.
  • 24. Fleming RV, Marques AR, Klempner MS, Schmid CH, Dally LG, Martin DS, et al. Pre-treatment and posttreatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 2004; 23(8): 615-8.
  • 25. Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection PLoS One. 2012; 7(1): e29914. doi: 10.1371/journal.pone.0029914.
  • 26. Shapiro ED. Repeat or persistent Lyme disease: persistence, recrudescence or reinfection with Borrelia Burgdorferi? 2015 Jan 5; 7:11. doi: 10.12703/P7-11.
  • 27. Marques A, Telford SR, Turk S, Chung E, Williams C, Dardick K, et al. Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. Clin Infect Dis. 2014; 58(7): 937-45.
  • 28. Chomel B. Lyme disease. Rev Sci Tech. 2015; 34(2): 569-76.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-5878ddf2-8cc0-4066-98d0-e6e42c76b72f
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.